Trials / Not Yet Recruiting
Not Yet RecruitingNCT06621680
Effect of Connective Tissue Massage on Premenstrual Syndrome
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 17 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to investigate the effect of connective tissue massage on premenstrual syndrome.
Detailed description
Premenstrual syndrome is a collection of emotional, physiological and behavioral symptoms that develop around the end of the luteal phase and fade away with or after mensturation. The physiological effects of connective tissue massage (CTM) are both local and general. Local effects include release of histamine from mast cells which leads to a triple response, local swelling and arteriolar dilatation mediated by local axon reflexes. The increased blood flow to the region assists resolution of subacute or chronic inflammation and reduces pain by removing nocigenic chemicals from the tissues. The mechanical distortions produced by CTM strokes help to mobilize connective tissue and improve function. Few studies have investigated the effect of the CTM on premenstrual syndrome in adolescent females. So this study will be conducted to add new information about the effect of connective tissue massage on premenstrual syndrome, which may help adolescent females suffering from this syndrome in decreasing their symptoms, thus adding new information to the field of physical therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Multivitamins | All participants will receive multivitamins (vitatron) capsule once daily, for 12 weeks. |
| OTHER | Connective tissue massage | Connective tissue massage will be applied on (Sacral, lumbar, last thoracic vertebrae-T12, and subcostal regions), 2 sessions/week for 20 minutes each session for 12 weeks. Treatment will begin 3 days before menstruation to the 4th day of menstruation for 3 successive menstrual cycles. |
Timeline
- Start date
- 2024-10-10
- Primary completion
- 2025-04-01
- Completion
- 2025-04-15
- First posted
- 2024-10-01
- Last updated
- 2024-10-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06621680. Inclusion in this directory is not an endorsement.